Recently, Shanghai Kehua Bio-engineering Co., Ltd., together with its subsidiary Tianlong Science and Technology, made a notable appearance at the 2025 American Association for Clinical Chemistry Annual Meeting & Clinical Lab Expo (ADLM 2025). Held at McCormick Place in Chicago from July 29 to 31, this international event gathered top players in the global diagnostic and laboratory medicine sector. KHB showcased its comprehensive in vitro diagnostic (IVD) solutions, engaging with global peers to discuss industry frontiers.

A Full Range of Products on Display, Demonstrating Strong Group Technical Strength

At the expo, KHB presented a core product portfolio covering clinical testing, blood screening safety, veterinary testing, and more. Highlights included the Polaris V150 Chemiluminescence Immunoassay Analyzer, FOCUS PEGASUS MF200 Automatic Multifunctional Veterinary Analyzer, as well as Tianlong's Panall 8000 Fully automated all-in-one #molecular diagnostic system, Gentier X3E/Gentier Mini+ real-time PCR platforms, and Biolum/Biolum Pro ATP hygiene monitoring systems. Hundreds of supporting IVD reagents were also on display, comprehensively demonstrating the group's full-industry-chain layout and innovative achievements in the IVD field.

Polaris V150: A "Crowd Favorite" in Clinical Testing

The V150 Chemiluminescence Immunoassay Analyzer emerged as a standout at the booth, drawing intense on-site discussions thanks to its core advantages of high precision, stability, full automation, and intelligent operation. Its strong reagent compatibility meets diverse testing needs, and it has already served hospitals and laboratories in multiple countries and regions, establishing itself as a reliable partner in clinical testing.

Blood Screening Solutions: Leading Technology Garners International Attention

KHB's technical prowess in blood screening safety also attracted significant attention. The second-generation nucleic acid blood screening reagents on display sparked widespread interest with their exceptional performance: detection limits as low as 1.087 IU/mL for hepatitis B, 3.385 IU/mL for hepatitis C, and 12.957 IU/mL and 22.592 IU/mL for HIV-1/2, respectively—all meeting internationally leading standards. When paired with KHB's automated nucleic acid blood screening workflow, the system enables fully automated processing from sample reception, scanning, sorting, and storage to cap opening/closing, extraction, PCR setup, and sealing, with no manual intervention required. This provides blood collection and supply institutions with an integrated, efficient, intelligent, and accurate solution for nucleic acid blood screening. A German client expressed strong interest in KHB's blood screening products and plans to initiate project testing, underscoring the products' international recognition.

FOCUS PEGASUS MF200 Automatic Multifunctional Veterinary Analyzer: An Innovative Benchmark in Veterinary Testing

Focus Pegasus MF200, from subsidiary Focus Biotechnology, also made an impressive debut. This all-in-one device integrates biochemistry, coagulation, immunology, and electrolyte testing, with core strengths in multi-functionality and full automation. It requires small sample volumes, is pet-friendly, and offers user-friendly operation with reliable performance. Its reagents support room-temperature transportation and storage (no cold chain needed), significantly reducing operational costs.

The product attracted high attention from U.S. clients: a U.S. chemical reagent company praised its compact design, high functional integration, user-friendly interface (ideal for the pet market), and comprehensive test reports (including complete patient information). The company expressed clear intent to collaborate, aiming to match its reagents with the MF200 to expand product line coverage.

Meanwhile, multiple clients from South America also showed strong interest. After learning about the device's multi-functional integration and room-temperature reagent storage, they expressed eagerness to conduct in-depth discussions on reagent adaptation, regional agency, and other cooperation models to promote the device's application in South America's pet healthcare sector.

Global Dialogue Fuels Cooperation, Jointly Shaping Industry Development

As a key player in the global IVD industry, KHB's participation was not just a showcase of technical achievements but also an opportunity for in-depth engagement with the international market. The team engaged in extensive discussions with industry partners worldwide on the latest IVD topics and application trends, covering clinical needs, technological innovation, product adaptation, and solution optimization. These multi-level dialogues laid a solid foundation for future cooperation.

Driven by Innovation, Embarking on a Global Journey

At ADLM 2025, KHB fully demonstrated the technical strength and brand appeal of Chinese IVD enterprises through its comprehensive product portfolio and integrated solutions. Looking ahead, the group will continue to focus on technological R&D, leverage synergies within the group, and refine its product layout. It aims to empower global healthcare with higher-quality products and services, collaborate with international partners to explore the boundless potential of the IVD field, and contribute to improving global diagnostic efficiency and health security.